Introduction: Satisfaction with anti-DM drug therapy can affect the effectiveness of and adherence to treatment in diabetic patients. This study aims to determine the description of satisfaction with anti-DM drug therapy for type 2 D.M. patients in primary care.
Method: The design of this study was a cross-sectional study of D.M. Patients. We included 109 DM Patients Participants. Data is collected from a perspective and carried out by face-to-face interviews using a questionnaire. We used the Therapy satisfaction questionnaire Medicine (TSQM) for assessing satisfaction with anti-DM drug therapy. We performed uni- and bivariate data analysis using the free-to-play version of SPSS. Characteristic of subject and TSQM scores were presented descriptively.
Result: The results of calculations with the help of SPSS version 25 are TSQM mean effectiveness domain 61.583 ± 11.598, side effects domain 54.011 ± 32.340, comfort domain 66.883 ± 8.805, global satisfaction domain 55.715 ± 11.274. Based on the research data, it is known that the level of global satisfaction therapy of D.M. patients in primary health facilities is sufficient. The lowest therapeutic domain of satisfaction is the domain of side effects, and the highest domain is the domain of satisfaction with comfort in drug therapy.
Conclusion: The level of D.M. patient satisfaction with anti-DM drug therapy is sufficient. Patients need to be educated about the possible emergence of side effects due to drug use.